128 related articles for article (PubMed ID: 16267391)
21. The human SNF5/INI1 protein facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity.
Wu DY; Tkachuck DC; Roberson RS; Schubach WH
J Biol Chem; 2002 Aug; 277(31):27706-15. PubMed ID: 12016208
[TBL] [Abstract][Full Text] [Related]
22. Cytoplasmic interaction of the tumour suppressor protein hSNF5 with dynamin-2 controls endocytosis.
Alfonso-Pérez T; Domínguez-Sánchez MS; García-Domínguez M; Reyes JC
Oncogene; 2014 Jun; 33(23):3064-74. PubMed ID: 23851497
[TBL] [Abstract][Full Text] [Related]
23. Human SNF5/INI1, a component of the human SWI/SNF chromatin remodeling complex, promotes nucleotide excision repair by influencing ATM recruitment and downstream H2AX phosphorylation.
Ray A; Mir SN; Wani G; Zhao Q; Battu A; Zhu Q; Wang QE; Wani AA
Mol Cell Biol; 2009 Dec; 29(23):6206-19. PubMed ID: 19805520
[TBL] [Abstract][Full Text] [Related]
24. Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5).
Das S; Banerjee B; Hossain M; Thangamuniyandi M; Dasgupta S; Chongdar N; Kumar GS; Basu G
PLoS One; 2013; 8(7):e66581. PubMed ID: 23861745
[TBL] [Abstract][Full Text] [Related]
25. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
Caramel J; Medjkane S; Quignon F; Delattre O
Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
[TBL] [Abstract][Full Text] [Related]
26. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA.
Lee D; Sohn H; Kalpana GV; Choe J
Nature; 1999 Jun; 399(6735):487-91. PubMed ID: 10365963
[TBL] [Abstract][Full Text] [Related]
27. The SWI/SNF subunit/tumor suppressor BAF47/INI1 is essential in cell cycle arrest upon skeletal muscle terminal differentiation.
Joliot V; Ait-Mohamed O; Battisti V; Pontis J; Philipot O; Robin P; Ito H; Ait-Si-Ali S
PLoS One; 2014; 9(10):e108858. PubMed ID: 25271443
[TBL] [Abstract][Full Text] [Related]
28. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.
Oruetxebarria I; Venturini F; Kekarainen T; Houweling A; Zuijderduijn LM; Mohd-Sarip A; Vries RG; Hoeben RC; Verrijzer CP
J Biol Chem; 2004 Jan; 279(5):3807-16. PubMed ID: 14604992
[TBL] [Abstract][Full Text] [Related]
29. RB1CC1 activates the p16 promoter through the interaction with hSNF5.
Ochi Y; Chano T; Ikebuchi K; Inoue H; Isono T; Arai A; Tameno H; Shimada T; Hisa Y; Okabe H
Oncol Rep; 2011 Oct; 26(4):805-12. PubMed ID: 21637919
[TBL] [Abstract][Full Text] [Related]
30. The role of INI1/hSNF5 in gene regulation and cancer.
Stojanova A; Penn LZ
Biochem Cell Biol; 2009 Feb; 87(1):163-77. PubMed ID: 19234532
[TBL] [Abstract][Full Text] [Related]
31. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
[TBL] [Abstract][Full Text] [Related]
32. hSNF5 /INI1 mutation analysis in acute myeloid leukemia.
Su YC; Chen CB; Chang YT; Tung YT; Li DK
Int J Hematol; 2008 Mar; 87(2):172-175. PubMed ID: 18266055
[TBL] [Abstract][Full Text] [Related]
33. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
Versteege I; Medjkane S; Rouillard D; Delattre O
Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
[TBL] [Abstract][Full Text] [Related]
34. The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells.
Albanese P; Belin MF; Delattre O
Eur J Cancer; 2006 Sep; 42(14):2326-34. PubMed ID: 16908131
[TBL] [Abstract][Full Text] [Related]
35. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.
Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O
Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283
[TBL] [Abstract][Full Text] [Related]
37. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
[TBL] [Abstract][Full Text] [Related]
38. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
39. Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance.
Das S; Cano J; Kalpana GV
J Biol Chem; 2009 Jul; 284(30):19903-14. PubMed ID: 19398554
[TBL] [Abstract][Full Text] [Related]
40. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance.
Yung E; Sorin M; Wang EJ; Perumal S; Ott D; Kalpana GV
J Virol; 2004 Mar; 78(5):2222-31. PubMed ID: 14963118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
